Perioperative Inflammation and Breast Cancer Outcome
Conditions
Breast Neoplasms
Conditions: official terms
Breast Neoplasms - Inflammation
Conditions: Keywords
Anti-Inflammatory Agents, Non-Steroidal, Inflammation, Perioperative Period
Study Type
Interventional
Study Phase
Phase 3
Study Design
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Intervention
Name: NSAIDS (ketorolac and ibuprofen)
Type: Drug
Overall Status
Not yet recruiting
Summary
It is increasingly recognized the NSAIDS (nonsteroidal antiinflammatory drug) might prevent the several cancers. In breast cancer, the role of NSAIDS (nonsteroidal antiinflammatory drug) has been suggested.However, there was no consistent results. surgery is main cause of inflammation for cancer patients. Therefore, we want to know the association between prevention of perioperative inflammation with NSAIDS and breast cancer outcomes.
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: 75 Years
Minimum Age: 18 Years
Gender: Female
Criteria: Inclusion Criteria:

- Breast cancer patients who took the surgery

Exclusion Criteria:

- underlying medical disease (major heart disease, lung disease, coagulopathy)

- major psychologic disease (major depression, schizophrenia, manic disorder)

- pregnancy

- rheumatic disease patients
Location
Samsung Medical Center
Seoul, Korea, Republic of
Status: Not yet recruiting
Contact: Se Kyung Lee, M.D. - 82-10-3014-0110 - sekyung.lee@samsung.com
Start Date
September 2014
Sponsors
Samsung Medical Center
Source
Samsung Medical Center
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page